Clinical Trials · NCT02154139
Leuprorelin Acetate SR 11.25 mg for Injection Specified Drug-use Survey "Long-term Use Survey on Premenopausal Breast Cancer Patients (96 Weeks)"
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Takeda
- Enrollment
- 651
- Start date
- Dec 2005
- Locations
- See registry
- Primary endpoint
- Number of Participants Reporting One or More Adverse Drug Reactions